The following is a summary of the Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript:

Financial Performance:

• Q4 revenue increased by 8% across all divisions, with an Adjusted EBITDA growth of 4% compared to the previous year.

• Full-year revenue from continuing operations grew by 7%, with Adjusted EBITDA growth of 14%, reaching $510.4 million.

• Adjusted earnings per share for Q4 was $0.18, compared to $0.12 in the same quarter the previous year.

• Interest expenses decreased due to debt refinancing, contributing to more favorable financial conditions.

Business Progress:

• Successfully completed the spinoff of Concentra and a major debt refinancing totaling $1.6 billion.

• Added 94 inpatient rehabilitation beds, acquired a 50-bed hospital, and opened two neuro transitional units.

• Plans for significant expansion including numerous new facilities totaling 481 additional beds in 2025 and 2026.

Opportunities:

• Expansion through acquiring and building new facilities, enhancing service capacity significantly across different regions.

• Increased financial efficiency through successful refinancing and cost optimization.

• Capitalizing on normalized nursing agency rates and reduced sign-on incentives, improving overall cost efficiency.

Risks:

• Start-up losses and integration costs from new facilities impacting short-term profitability.

• Potential disruptions in referrals affecting operational consistency, as seen with Hurricane Helene's impact on partner facilities.

More details: Select Medical Holdings IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.